<?xml version="1.0" encoding="UTF-8"?>
<p>In addition to the circulation, we also assessed the impact of DT administration on cell populations in the muscle tissue of control and RRV-T48-infected mice (
 <xref ref-type="fig" rid="ppat.1006748.g001">Fig 1D</xref> and 
 <xref ref-type="supplementary-material" rid="ppat.1006748.s003">S3 Fig</xref>). At 48 h after the last DT administration, we quantified leukocytes in enzymatically-digested muscle tissue by flow cytometry. Muscle tissue from mock-infected mice had low numbers of NK cells and Ly6C
 <sup>hi</sup>CD11b
 <sup>+</sup> cells that were depleted in DT-treated CCR2-DTR mice. We also detected a population of Ly6C
 <sup>+</sup>CD11b
 <sup>+</sup>CD11c
 <sup>+</sup>CD64
 <sup>+</sup>Ly6G
 <sup>-</sup> cells that was unaffected in DT-treated CCR2-DTR mice (
 <xref ref-type="fig" rid="ppat.1006748.g001">Fig 1D</xref> and 
 <xref ref-type="supplementary-material" rid="ppat.1006748.s003">S3 Fig</xref>). NK cells and Ly6C
 <sup>hi</sup> cell populations were increased in muscle tissue of RRV-T48-infected mice, and these cells were depleted in RRV-T48-infected CCR2-DTR mice (
 <xref ref-type="fig" rid="ppat.1006748.g001">Fig 1D</xref> and 
 <xref ref-type="supplementary-material" rid="ppat.1006748.s003">S3 Fig</xref>). The Ly6C
 <sup>+</sup>CD11b
 <sup>+</sup>CD11c
 <sup>+</sup>CD64
 <sup>+</sup>Ly6G
 <sup>-</sup> cell population found in muscle tissue of mock-infected mice also was unaffected following DT treatment of RRV-T48-infected CCR2-DTR mice (
 <xref ref-type="fig" rid="ppat.1006748.g001">Fig 1D</xref> and 
 <xref ref-type="supplementary-material" rid="ppat.1006748.s003">S3 Fig</xref>). These data indicate that DT treatment of CCR2-DTR mice reduces accumulation of NK cells and Ly6C
 <sup>hi</sup> monocytes in muscle tissue.
</p>
